Efficacy and safety of routine post-dilatation using a balloon-expandable transcatheter aortic valve implantation platform - the randomized controlled DUOTAP trial.

28 August 2026 (14:15 - 14:30)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Maximilian Autherith

Medical University of Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail

EuroHeart - TAVI Registry

Professor R. Kharbanda (Oxford, GB)

Presentation thumbnail

Optimal Medical Treatment With or Without Valve Repair in Patients with symptomatic Paradoxical Low-Flow, Low-Gradient Aortic Stenosis: a multicenter, randomized comparison

Professor J. Mehilli (Landshut, DE)

Presentation thumbnail

EMPagliflozin after Aortic Valve Replacement study: a randomized clinical trial

Doctor L. Soerensen (Copenhagen, DK)

Presentation thumbnail

Prosthesis-Patient Mismatch after Transcatheter or Surgical Treatment of Aortic Valve Stenosis: A Sub-Study of the Randomized DEDICATE-DZHK6 Trial

Doctor T. Rheude (Munich, DE)

Access the full session

Session thumbnail

Late-Breaking Clinical Science: valvular heart disease

The Event

Event poster

ESC Congress 2026

28 August 2026 14:15 CET

You may be interested in

Congress Session

TAVI: technical aspects in special populations

31 August 2024

Congress Presentation

Comparison of the effects of pre-dilatation with conventional versus larger balloon sizes on clinical outcomes in transcatheter aortic valve implantation with self-expandable valves

31 August 2024

Congress Session

HOT LINE 6

31 August 2025

Congress Session

Late-breaking science on valve disease and hypertrophic cardiomyopathy

28 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources